Conference Coverage: ESMO 2021 – FOCUS ON GU
Impact of recent ESMO data on clinical practice and therapy guidance in genitourinary cancer
September 22, 2021
FACULTY CHAIR
Daniel Petrylak, MD
Yale Cancer Center, New Haven, CT, USA
Faculty Members
Karim Fizazi, MD, PhD
Institute Gustave Roussy, Villejuif, France
Oliver Sartor, MD
Tulane Cancer Center, New Orleans, LA, US
Manuela Schmidinger, MD
Medical University of Vienna, Vienna, Austria
Susan Slovin, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, US
Thomas Powles, MD, MBBS, MRCP
Barts Cancer Institute, London, UK
Scott Tagawa, MD, FACP
Weill Cornell Medical Center, New York, NY, US
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Renal Cell Carcinoma
- Prostate Cancer – Hormonal Therapies, Resistance, and Imaging
- Cytotoxic, Immune, and Targeted Therapies for Metastatic Prostate Cancer
- Bladder Cancer
